| 1 | 91524-15-1 | 伊洛沙星 | Irloxacin | C16H13FN2O3
| | |
| 2 | 574720-99-3 | N-(4-fluorobenzyl)-3-{3-nitrophenyl}acrylamide | N-(4-fluorobenzyl)-3-{3-nitrophenyl}acrylamide | C16H13FN2O3
| | |
| 3 | 479690-24-9 | 4-(4-氨基-2-氟苯氧基)-6-甲氧基奎琳-7-醇 | 4-(4-amino-2-fluorophenoxy)-6-methoxyquinolin-7-ol | C16H13FN2O3
| | |
| 4 | 331462-41-0 | N-(5-FLUORO-2-METHYLPHENYL)-3-(3-NITROPHENYL)ACRYLAMIDE | N-(5-FLUORO-2-METHYLPHENYL)-3-(3-NITROPHENYL)ACRYLAMIDE | C16H13FN2O3
| | |
| 5 | 309734-23-4 | 2-(3,4-dimethoxyphenyl)-5-(3-fluorophenyl)-1,3,4-oxadiazole | 2-(3,4-dimethoxyphenyl)-5-(3-fluorophenyl)-1,3,4-oxadiazole | C16H13FN2O3
| | |
| 6 | 1630101-74-4 | 2-((1H-吡咯并[2,3-B]吡啶-5-基)氧基)-4-溴苯甲酸乙酯 | Ethyl2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate | C16H13FN2O3
| | |
| 7 | 445287-45-6 | N'-[1-(1,3-benzodioxol-5-yl)ethylidene]-3-fluorobenzohydrazide | N'-[1-(1,3-benzodioxol-5-yl)ethylidene]-3-fluorobenzohydrazide | C16H13FN2O3
| | |
| 8 | | (E)-3-(4-fluorophenyl)-N-(2-methyl-5-nitrophenyl)-2-propenamide | (E)-3-(4-fluorophenyl)-N-(2-methyl-5-nitrophenyl)-2-propenamide | C16H13FN2O3
| | |
| 9 | 297147-95-6 | | 4-[4-(4-fluorophenoxy)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol | C16H13FN2O3
| | |
| 10 | 252058-84-7 | ETHYL 2-[3-CYANO-6-(4-FLUOROPHENYL)-2-OXO-1(2H)-PYRIDINYL]ACETATE | ETHYL 2-[3-CYANO-6-(4-FLUOROPHENYL)-2-OXO-1(2H)-PYRIDINYL]ACETATE | C16H13FN2O3
| | |
| 11 | 387346-21-6 | 4(1H)-Quinazolinone, 2-[(4-fluorophenoxy)methyl]-8-methoxy- (9CI) | 4(1H)-Quinazolinone, 2-[(4-fluorophenoxy)methyl]-8-methoxy- (9CI) | C16H13FN2O3
| | |
| 12 | 1888293-74-0 | 3-(5-fluoro-6-phenyl-2,3-dihydrofuro[2,3-b]pyridin-4-yl)oxazolidin-2-one | 3-(5-fluoro-6-phenyl-2,3-dihydrofuro[2,3-b]pyridin-4-yl)oxazolidin-2-one | C16H13FN2O3
| | |
| 13 | | 3-(2-fluorobenzyl)-5-[(5-methyl-2-furyl)methylene]-2,4-imidazolidinedione | 3-(2-fluorobenzyl)-5-[(5-methyl-2-furyl)methylene]-2,4-imidazolidinedione | C16H13FN2O3
| | |
| 14 | 104029-64-3 | 2-Benzoxazolemethanol, α-(2-fluorophenyl)-, methylcarbamate (ester) (9CI) | 2-Benzoxazolemethanol, α-(2-fluorophenyl)-, methylcarbamate (ester) (9CI) | C16H13FN2O3
| | |
| 15 | 1268867-01-1 | methyl 2-(4-fluorophenyl)-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate | methyl 2-(4-fluorophenyl)-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate | C16H13FN2O3
| | |
| 16 | | 5-(5-FLUORO-2-HYDROXYBENZOYL)-2-OXO-1-PROPYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | 5-(5-FLUORO-2-HYDROXYBENZOYL)-2-OXO-1-PROPYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | C16H13FN2O3
| | |
| 17 | 1081139-68-5 | {4-[(1Z)-2-(2-fluorophenyl)-N-hydroxyethanimidoyl]-3-hydroxyphenoxy}acetonitrile | {4-[(1Z)-2-(2-fluorophenyl)-N-hydroxyethanimidoyl]-3-hydroxyphenoxy}acetonitrile | C16H13FN2O3
| | |
| 18 | | 5-(5-FLUORO-2-HYDROXYBENZOYL)-1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | 5-(5-FLUORO-2-HYDROXYBENZOYL)-1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | C16H13FN2O3
| | |
| 19 | 356068-93-4 | 5-((Z)-(5-氟-2-氧代吲哚烷-3-亚基)甲基)-2,4-二甲基-1H-吡咯-3-羧酸 | 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | C16H13FN2O3
| 医药中间体;杂质对照品;舒尼替尼中间体;抗癌药：包括舒尼替尼，厄洛替尼，Foretinib | |
| 20 | 452105-33-8 | 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid | 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid | C16H13FN2O3
| | |
| 21 | 868551-51-3 | 1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid, 1-[(4-fluorophenyl)methyl]-4-hydroxy-, methyl ester | 1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid, 1-[(4-fluorophenyl)methyl]-4-hydroxy-, methyl ester | C16H13FN2O3
| | |